
Relmada Therapeutics, Inc.
RLMDNasdaqCIK 1553643HealthcareFiscal year ends Dec 31
Reports and events: 239 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0816:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-084737 |
| 2023-11-0816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-084735 |
| 2023-10-1109:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013762-23-002985 |
| 2023-10-1017:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001013762-23-002900 |
| 2023-10-0408:53 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001013762-23-001391 |
| 2023-09-2016:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-078049 |
| 2023-09-0609:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-23-074165 |
| 2023-08-1016:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-065674 |
| 2023-08-0816:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-064577 |
| 2023-08-0816:01 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-064519 |
| 2023-05-2516:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-23-043101 |
| 2023-05-1517:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-040004 |
| 2023-05-1116:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-038577 |
| 2023-05-1116:07 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001213900-23-038533 |
| 2023-04-1909:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-030851 |
| 2023-03-3109:00 ET | DEF 14A | Proxy statementPeriod 2023-05-25 | 0001213900-23-025007 |
| 2023-03-2316:49 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001213900-23-022463 |
| 2023-03-2316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-022428 |
| 2023-03-1308:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001213900-23-019392 |
| 2023-01-1717:34 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-23-002865 |
| 2023-01-0908:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-001518 |
| 2023-01-0517:28 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-001162 |
| 2022-12-2817:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-22-083290 |
| 2022-12-0716:58 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-078255 |
| 2022-11-1406:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-071463 |
| 2022-11-1017:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-071296 |
| 2022-11-1016:06 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001213900-22-071154 |
| 2022-10-1309:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-063664 |
| 2022-09-2217:19 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-22-058066 |
| 2022-09-2016:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-057439 |
| 2022-08-1116:48 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001213900-22-046934 |
| 2022-06-0109:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-22-030586 |
| 2022-05-0516:54 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-024268 |
| 2022-05-0516:05 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001213900-22-024229 |
| 2022-04-1116:15 ET | DEF 14A | Proxy statementPeriod 2022-05-25 | 0001213900-22-019196 |
| 2022-03-2507:53 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001213900-22-015012 |
| 2022-03-2316:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-014492 |
| 2022-03-0716:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-010929 |
| 2022-02-2306:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-008783 |
| 2021-12-2217:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-067091 |
| 2021-12-2017:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-066436 |
| 2021-12-1317:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-21-065014 |
| 2021-12-0717:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-063985 |
| 2021-11-2310:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-061444 |
| 2021-11-1508:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-058993 |
| 2021-11-1209:10 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001213900-21-058454 |
| 2021-10-0717:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-051860 |
| 2021-08-1016:03 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001213900-21-041369 |
| 2021-07-2016:45 ET | 8-K | 1.01 Entry into a material agreement | 0001213900-21-037756 |
| 2021-05-2017:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-21-028217 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.